Sfoglia per Rivista
A Bayesian approach to non-parametric AUC estimation in population studies
2003-01-01 Magni, Paolo; Bellazzi, Riccardo; DE NICOLAO, Giuseppe; Simeoni, Monica; Germani, MASSIMILIANO ENRICO; I., Poggesi; M., Rocchetti
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies
2011-01-01 DEL BENE, Francesca; Terranova, Nadia; F., Fiorentini; Germani, MASSIMILIANO ENRICO; Magni, Paolo
A new, second-order indirect model of depression time course
2012-01-01 Russu, Alberto; Marostica, Eleonora; S., Zamuner; I., Poggesi; R., Gomeni; DE NICOLAO, Giuseppe
A non parametric population approach for selecting biomarkers of a drug action
2011-01-01 Terranova, Nadia; DEL BENE, Francesca; F., Fiorentini; Magni, Paolo; Germani, MASSIMILIANO ENRICO
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice
2013-01-01 Germani, MASSIMILIANO ENRICO; M., Rocchetti; DEL BENE, Francesca; Terranova, Nadia; I., Poggesi; DE NICOLAO, Giuseppe; Magni, Paolo
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab.
2013-01-01 Mezzalana, Enrica; A., Macdonald; DE NICOLAO, Giuseppe; S., Zamuner
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases.
2012-01-01 Mezzalana, Enrica; A., Macdonald; R., Bizzotto; DE NICOLAO, Giuseppe; S., Zamuner
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement
2014-01-01 Mezzalana, Enrica; K., Page; A., van Maurik; A., Mcdonald; DE NICOLAO, Giuseppe; S., Zamuner
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight
2014-01-01 Terranova, Nadia; DEL BENE, Francesca; Germani, MASSIMILIANO ENRICO; M., Rocchetti; Magni, Paolo
Artificial intelligence and machine learning: just a hype or a new opportunity for pharmacometrics?
2019-01-01 Bartolucci, R.; Grandoni, S.; Melillo, N.; Nicora, G.; Sauta, E.; Tosca, E. M.; Magni, P.
Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter
2015-01-01 Larizza, Cristiana; Pasotti, Lorenzo; Mezzalana, Enrica; Borella, Elisa; Smith, G.; Magni, Paolo
A clinical trial simulator to predict the effect of an adaptive dosing regimen of an investigated compound on platelets, white blood cells and haematocrit in patients with Polycythemia Vera
2022-01-01 Tosca, E. M.; Bartolucci, R.; Castellano, S.; Fiorentini, F.; Manzoni, S.; Di Tollo, S.; Caserini, M.; Rocchetti, M.; Bettica, P.; Magni, P.
Development and evaluation of a PBPK model to study the pharmacokinetics of inhaled drugs in rats
2019-01-01 Grandoni, S.; Cesari, N.; Melillo, N.; Brogin, G.; Puccini, P.; Magni, P.
Development and integration of the WinBUGS connector in the DDMoRe Interoperability Framework
2016-01-01 Larizza, Cristiana; Borella, Elisa; Pasotti, Lorenzo; Smith, G.; Kaye, R.; Magni, Paolo
Development of a genetic algorithm for covariate analysis in population pharmacokinetic models
2021-01-01 Bartolucci, R.; Masciale, G.; Tosca, E. M.; Magni, P.
Dynamic Energy Budget (DEB) based models of tumor-in-host growth inhibition and cachexia onset
2019-01-01 Tosca, E. M.; Rocchetti, M.; Pesenti, E.; Magni, P.
Evaluating the inclusion of the particle size distribution in the lung dissolution model of a WB-PBPK model to describe the pharmacokinetics of inhaled polydisperse drugs
2018-01-01 Grandoni, S.; Cesari, N.; Brogin, G.; Puccini, P.; Magni, P.
Evaluating the Influence of Different Sources of Variability in the PK/PD Tumor Growth Inhibition (TGI) Model
2008-01-01 F., Del Bene; M., Germani; F., Fiorentini; DE NICOLAO, Giuseppe; Magni, Paolo; M., Rocchetti
Evaluation of a minimal WB-PBPK platform supporting different routes of administration
2017-01-01 Grandoni, Silvia; Bigoni, Giulia; Cesari, N.; Puccini, P.; Brogin, G.; Magni, Paolo
Evaluation of a PK/PD DEB-based model for tumor-in-host growth kinetics under anticancer treatment
2016-01-01 Tosca, ELENA MARIA; Borella, Elisa; Terranova, Nadia; Rocchetti, M.; Magni, Paolo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile